• FDA Approves Immgolis (golimumab-sldi) and Immgolis Intri (golimumab-sldi) as the First Interchangeable Biosimilars to Simponi and Simponi Aria

  May 15, 2026 — The FDA has approved Immgolis (golimumab-sldi) as an interchangeable biosimilar to Simponi (golimumab), and Immgolis Intri (golimumab-s···【Read More】

  Update: 18 May,2026Source: BigbearViews: 131

• EU Approves New Expanded Indications for Dabrafenib and Trametinib!

  The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending amendmen···【Read More】

  Update: 11 May,2026Source: BigbearViews: 143